Simulation of homology models for the extracellular domains (ECD) of ErbB3, ErbB4 and the ErbB2-ErbB3 complex in their active conformations

Journal of Molecular Modeling

Volumn 19, Issue 2, 2013, Pages 931-941

  Franco Gonzalez, Juan Felipe ^a   Ramos, Javier ^a   Cruz, Victor L ^a   Martínez Salazar, Javier ^a  

^a INSTITUTO DE ESTRUCTURA DE LA MATERIA   (Spain)

Author keywords

EGFR receptors; Homology modeling; Molecular dynamics simulation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; HETERODIMER;

ARTICLE; CARCINOGENESIS; CRYSTALLOGRAPHY; DIMERIZATION; EXTRACELLULAR DOMAIN; MEMBRANE STRUCTURE; MOLECULAR MODEL; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN INTERACTION; SIMULATION;

HUMANS; LIGANDS; MOLECULAR DYNAMICS SIMULATION; NEUREGULIN-1; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; STRUCTURAL HOMOLOGY, PROTEIN; WATER;

EID: 84877134677     PISSN: 16102940     EISSN: 09485023     Source Type: Journal    
DOI: 10.1007/s00894-012-1613-y     Document Type: Article

References (40)

1. Wieduwilt M, Moasser M (2008) The epidermal growth factor receptor family: biology driving targeted therapeutics. Cell Mol Life Sci 65(10):1566-1584. doi: 10.1007/s00018-008-7440-8
2. Cho H-S, Leahy DJ (2002) Structure of the extracellular region of HER3 reveals an interdomain tether. Science 297(5585):1330-1333. doi: 10.1126/science.1074611
3. Ferguson KM, Berger MB, Mendrola JM, Cho H-S, Leahy DJ, Lemmon MA (2003) EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol Cell 11(2):507-517
4. Li S, Schmitz KR, Jeffrey PD, Wiltzius JJW, Kussie P, Ferguson KM (2005) Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell 7(4):301-311
5. Bouyain S, Longo PA, Li S, Ferguson KM, Leahy DJ (2005) The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand. Proc Natl Acad Sci USA 102(42):15024-15029. doi: 10.1073/pnas.0507591102
6. Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim J-H, Saito K, Sakamoto A, Inoue M, Shirouzu M, Yokoyama S (2002) Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110(6):775-787
7. Garrett TPJ, McKern NM, Lou M, Elleman TC, Adams TE, Lovrecz GO, Zhu H-J, Walker F, Frenkel MJ, Hoyne PA, Jorissen RN, Nice EC, Burgess AW, Ward CW (2002) Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor α. Cell 110(6):763-773
8. Cho H-S, Mason K, Ramyar KX, Stanley AM, Gabelli SB, Denney DW, Leahy DJ (2003) Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421 (6924):756-760 http://www.nature.com/nature/ journal/v421/n6924/suppinfo/nature01392-S1.html
9. Franklin MC, Carey KD, Vajdos FF, Leahy DJ, de Vos AM, Sliwkowski MX (2004) Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer Cell 5(4):317-328
10. Lu C, Mi n-Z, Grey MJ, Zhu J, Graef E, Yokoyama S, Springer TA (2010) Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor. Mol Cell Biol 30(22):5432-5443. doi: 10.1128/mcb.00742-10
11. Lemmon MA (2009) Ligand-induced ErbB receptor dimerization. Exp Cell Res 315(4):638-648
12. Chung I, Akita R, Vandlen R, Toomre D, Schlessinger J, Mellman I (2010) Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature 464 (7289):783-787 http://www.nature.com/nature/journal/v464/ n7289/suppinfo/nature08827-S1.html
13. Brennan PJ, Kumagai T, Berezov A, Murali R, Greene MI (2000) HER2/neu: mechanisms of dimerization/oligomerization. Oncogene 19(53):6093-6101. doi: 10.1038/sj.onc.1203967
14. Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2(2):127-137. doi: 10.1038/35052073
15. Luo C, Xu L, Zheng S, Luo X, Shen J, Jiang H, Liu X, Zhou M (2005) Computational analysis of molecular basis of 1:1 interactions of NRG-1beta wild-type and variants with ErbB3 and ErbB4. Proteins 59(4):742-756. doi: 10.1002/prot.20443
16. Hynes NE, Lane HA (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5(5):341-354. doi: 10.1038/nrc1609
17. Baselga J, Swain SM (2009) Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer 9(7):463-475. doi: 10.1038/nrc2656
18. Fuentes G, Scaltriti M, Baselga J, Verma C (2011) Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism. Breast Cancer Res 13(3):R54
19. Du Y, Yang H, Xu Y, Cang X, Luo C, Mao Y, Wang Y, Qin G, Luo X, Jiang H (2012) Conformational transition and energy landscape of ErbB4 activated by neuregulin1β: one microsecond molecular dynamics simulations. J Am Chem Soc 134(15):6720-6731. doi: 10.1021/ja211941d
20. Bagossi P, Horváth G, Vereb G, Szöllösi J, Tözsér J (2005) Molecular modeling of nearly full-length ErbB2 receptor. Biophys J 88(2):1354-1363
21. Henikoff S, Henikoff JG (1992) Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci USA 89(22):10915-10919
22. Cheng J, Randall AZ, Sweredoski MJ, Baldi P (2005) SCRATCH: a protein structure and structural feature prediction server. Nucleic Acids Res 33(suppl 2):W72-W76. doi: 10.1093/nar/gki396
23. (2011) Maestro, version 9.2, Schrödinger. LLC, New York, NY
24. SYBYL 8.0, Tripos International, St. Louis, MO
25. Dayhoff M, Schwartz R, Orcutt B (1978) Atlas of protein sequence and structure. National biomedical research foundation. National Biomedical Research Foundation, Washington DC, pp 5-345
26. Hess B, Kutzner C, van der Spoel D, Lindahl E (2008) GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 4(3):435-447. doi: 10.1021/ct700301q
27. Jorgensen WL, Tirado-Rives J (1988) The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J Am Chem Soc 110(6):1657-1666. doi: 10.1021/ja00214a001
28. Jorgensen WL, Tirado-Rives J (2005) Potential energy functions for atomic-level simulations of water and organic and biomolecular systems. Proc Natl Acad Sci USA 102(19):6665-6670. doi: 10.1073/pnas.0408037102
29. Lawrence CP, Skinner JL (2003) Flexible TIP4P model for molecular dynamics simulation of liquid water. Chem Phys Lett 372(5-6):842-847
30. Berendsen H, Postma J, van Gunsteren W, Hermans J (1981) Interaction models for water in realtion of protein hydration. In: Pullman B (ed) Intermolecular forces. Reidel, Dordrecht, pp 331-342
31. Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an N [center-dot] log(N) method for Ewald sums in large systems. J Chem Phys 98(12):10089-10092
32. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG (1995) A smooth particle mesh Ewald method. J Chem Phys 103(19):8577-8593
33. Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81(8):3684-3690
34. Hess B, Bekker H, Berendsen HJC, Fraaije JGEM (1997) LINCS: A linear constraint solver for molecular simulations. J Comput Chem 18(12):1463-1472. doi: 10.1002/(sici)1096-987x(199709)18:12<1463::aid-jcc4>3.0.co;2-h
35. Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14(1):33-38, 27-38
36. Amadei A, Linssen ABM, Berendsen HJC (1993) Essential dynamics of proteins. Proteins Struct Funct Bioinforma 17(4):412-425. doi: 10.1002/prot.340170408
37. Amadei A, Linssen AB, de Groot BL, van Aalten DM, Berendsen HJ (1996) An efficient method for sampling the essential subspace of proteins. J Biomol Struct Dyn 13(4):615-625
38. Kabsch W, Sander C (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22(12):2577-2637. doi: 10.1002/bip.360221211
39. Jacobsen NE, Abadi N, Sliwkowski MX, Reilly D, Skelton NJ, Fairbrother WJ (1996) High-resolution solution structure of the EGF-like domain of heregulin-α‡. Biochemistry 35(11):3402-3417. doi: 10.1021/bi952626l
40. Nagata K, Kohda D, Hatanaka H, Ichikawa S, Matsuda S, Yamamoto T, Suzuki A, Inagaki F (1994) Solution structure of the epidermal growth factor-like domain of heregulin-alpha, a ligand for p180erbB-4. EMBO J 13(15):3517-3523